TNTRQ yields 4000000.00% · JNJ yields 2.13%● Live data
📍 TNTRQ pulled ahead of the other in Year 1
Combined, TNTRQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TNTRQ + JNJ for your $10,000?
Tintri, Inc. develops and markets an enterprise cloud platform combining cloud management software technology and a range of all-flash storage systems for virtualized and cloud environments in the United States and internationally. The company's platform provides large organizations and cloud service providers with public cloud capabilities inside their data centers and public cloud services. Its products and technologies include Tintri CONNECT, a proprietary software architecture for virtualized and cloud applications; Tintri OS, which helps the interaction between the virtualized infrastructure and the underlying storage serving that infrastructure; Tintri Global Center, an intelligent data and system management product; and VM Scale-out software, which creates resource pools of Tintri storage systems and optimizes the location of applications. The company's products and technologies also include predictive analytics solutions for customers to model their current and future storage requirements; ReplicateVM, the replication solutions for data protection and disaster recovery; SyncVM, a solution for copy data management; SecureVM, a solution for encryption of data-at-rest; Tintri Cloud Connector, which allows customers to use public cloud storage for storing snapshots; and storage systems, such as EC6000 all-flash systems, T800 hybrid-flash systems, and T1000 all-flash system. It also offers its products related support, installation, and training services. The company serves customer in education, financial services, insurance, healthcare, manufacturing, and automotive technology, as well as cloud service providers. Tintri, Inc. was founded in 2008 and is headquartered in Mountain View, California. On July 10, 2018, Tintri, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on October 8, 2019.
Full TNTRQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.